119 related articles for article (PubMed ID: 22670682)
1. Characterization of CD4⁺ cytotoxic lymphocytes and apoptosis markers induced by Trypanossoma cruzi infection.
Keesen TS; Gomes JA; Fares RC; de Araújo FF; Ferreira KS; Chaves AT; Rocha MO; Correa-Oliveira R
Scand J Immunol; 2012 Sep; 76(3):311-9. PubMed ID: 22670682
[TBL] [Abstract][Full Text] [Related]
2. Immunoregulatory mechanisms in Chagas disease: modulation of apoptosis in T-cell mediated immune responses.
Chaves AT; de Assis Silva Gomes Estanislau J; Fiuza JA; Carvalho AT; Ferreira KS; Fares RC; Guimarães PH; de Souza Fagundes EM; Morato MJ; Fujiwara RT; da Costa Rocha MO; Correa-Oliveira R
BMC Infect Dis; 2016 Apr; 16():191. PubMed ID: 27138039
[TBL] [Abstract][Full Text] [Related]
3. Foxp3+CD25(high) CD4+ regulatory T cells from indeterminate patients with Chagas disease can suppress the effector cells and cytokines and reveal altered correlations with disease severity.
de Araújo FF; Corrêa-Oliveira R; Rocha MO; Chaves AT; Fiuza JA; Fares RC; Ferreira KS; Nunes MC; Keesen TS; Damasio MP; Teixeira-Carvalho A; Gomes JA
Immunobiology; 2012 Aug; 217(8):768-77. PubMed ID: 22672991
[TBL] [Abstract][Full Text] [Related]
4. Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease.
Souza PE; Rocha MO; Menezes CA; Coelho JS; Chaves AC; Gollob KJ; Dutra WO
Infect Immun; 2007 Apr; 75(4):1886-94. PubMed ID: 17283096
[TBL] [Abstract][Full Text] [Related]
5. Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease.
Vitelli-Avelar DM; Sathler-Avelar R; Teixeira-Carvalho A; Pinto Dias JC; Gontijo ED; Faria AM; Elói-Santos SM; Martins-Filho OA
Scand J Immunol; 2008 Nov; 68(5):516-25. PubMed ID: 18803607
[TBL] [Abstract][Full Text] [Related]
6. Benznidazole treatment during early-indeterminate Chagas' disease shifted the cytokine expression by innate and adaptive immunity cells toward a type 1-modulated immune profile.
Sathler-Avelar R; Vitelli-Avelar DM; Massara RL; Borges JD; Lana M; Teixeira-Carvalho A; Dias JC; Elói-Santos SM; Martins-Filho OA
Scand J Immunol; 2006 Nov; 64(5):554-63. PubMed ID: 17032249
[TBL] [Abstract][Full Text] [Related]
7. Activation-induced T cell death exacerbates Trypanosoma cruzi replication in macrophages cocultured with CD4+ T lymphocytes from infected hosts.
Nunes MP; Andrade RM; Lopes MF; DosReis GA
J Immunol; 1998 Feb; 160(3):1313-9. PubMed ID: 9570549
[TBL] [Abstract][Full Text] [Related]
8. Isolation from Trypanosoma cruzi-infected mice of CD8+, MHC-restricted cytotoxic T cells that lyse parasite-infected target cells.
Nickell SP; Stryker GA; Arevalo C
J Immunol; 1993 Feb; 150(4):1446-57. PubMed ID: 8432987
[TBL] [Abstract][Full Text] [Related]
9. Activation-induced CD4+ T cell death by apoptosis in experimental Chagas' disease.
Lopes MF; da Veiga VF; Santos AR; Fonseca ME; DosReis GA
J Immunol; 1995 Jan; 154(2):744-52. PubMed ID: 7814881
[TBL] [Abstract][Full Text] [Related]
10. Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes.
Vitelli-Avelar DM; Sathler-Avelar R; Dias JC; Pascoal VP; Teixeira-Carvalho A; Lage PS; Elói-Santos SM; Corrêa-Oliveira R; Martins-Filho OA
Scand J Immunol; 2005 Sep; 62(3):297-308. PubMed ID: 16179017
[TBL] [Abstract][Full Text] [Related]
11. Caspase inhibition reduces lymphocyte apoptosis and improves host immune responses to Trypanosoma cruzi infection.
Silva EM; Guillermo LV; Ribeiro-Gomes FL; De Meis J; Nunes MP; Senra JF; Soares MB; DosReis GA; Lopes MF
Eur J Immunol; 2007 Mar; 37(3):738-46. PubMed ID: 17295391
[TBL] [Abstract][Full Text] [Related]
12. Trypanosoma cruzi inhibits the expression of CD3, CD4, CD8, and IL-2R by mitogen-activated helper and cytotoxic human lymphocytes.
Sztein MB; Cuna WR; Kierszenbaum F
J Immunol; 1990 May; 144(9):3558-62. PubMed ID: 2139458
[TBL] [Abstract][Full Text] [Related]
13. CD86 Expression by Monocytes Influences an Immunomodulatory Profile in Asymptomatic Patients with Chronic Chagas Disease.
Pinto BF; Medeiros NI; Teixeira-Carvalho A; Eloi-Santos SM; Fontes-Cal TCM; Rocha DA; Dutra WO; Correa-Oliveira R; Gomes JAS
Front Immunol; 2018; 9():454. PubMed ID: 29599775
[TBL] [Abstract][Full Text] [Related]
14. The Fas death pathway controls coordinated expansions of type 1 CD8 and type 2 CD4 T cells in Trypanosoma cruzi infection.
Guillermo LV; Silva EM; Ribeiro-Gomes FL; De Meis J; Pereira WF; Yagita H; DosReis GA; Lopes MF
J Leukoc Biol; 2007 Apr; 81(4):942-51. PubMed ID: 17261545
[TBL] [Abstract][Full Text] [Related]
15. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
Braun M; de Titto E
Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
[TBL] [Abstract][Full Text] [Related]
16. PD1 and PDL1 molecules control suppressor activity of regulatory T cells in chronic Chagas cardiomyopathy patients.
Damasio MPS; Rocha MOC; Sousa GR; Ferreira KS; Fares-Gusmão RCG; Medeiros NI; Araujo FF; Chaves AT; Dutra WO; Correa-Oliveira R; Gomes JAS
Hum Immunol; 2019 Jul; 80(7):517-522. PubMed ID: 30853363
[TBL] [Abstract][Full Text] [Related]
17. The cytotoxic protease granzyme M is expressed by lymphocytes of both the innate and adaptive immune system.
de Koning PJ; Tesselaar K; Bovenschen N; Colak S; Quadir R; Volman TJ; Kummer JA
Mol Immunol; 2010 Jan; 47(4):903-11. PubMed ID: 19896187
[TBL] [Abstract][Full Text] [Related]
18. Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients.
Pérez-Antón E; Egui A; Thomas MC; Puerta CJ; González JM; Cuéllar A; Segovia M; López MC
PLoS Negl Trop Dis; 2018 May; 12(5):e0006480. PubMed ID: 29750791
[TBL] [Abstract][Full Text] [Related]
19. Cytokine levels in serious cardiopathy of Chagas disease after in vitro stimulation with recombinant antigens from Trypanosoma cruzi.
Lorena VM; Lorena IM; Braz SC; Melo AS; Melo MF; Melo MG; Silva ED; Ferreira AG; Morais CN; Costa VM; Correa-Oliveira R; Gomes YM
Scand J Immunol; 2010 Dec; 72(6):529-39. PubMed ID: 21044127
[TBL] [Abstract][Full Text] [Related]
20. T-bet inhibits the in vivo differentiation of parasite-specific CD4+ Th17 cells in a T cell-intrinsic manner.
Guo S; Cobb D; Smeltz RB
J Immunol; 2009 May; 182(10):6179-86. PubMed ID: 19414771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
